Cargando…

The Effect of ß-Glucan Prebiotic on Kidney Function, Uremic Toxins and Gut Microbiome in Stage 3 to 5 Chronic Kidney Disease (CKD) Predialysis Participants: A Randomized Controlled Trial

There is growing evidence that gut dysbiosis contributes to the progression of chronic kidney disease (CKD) owing to several mechanisms, including microbiota-derived uremic toxins, diet and immune-mediated factors. The aim of this study was to investigate the effect of a ß-glucan prebiotic on kidney...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ebrahim, Zarina, Proost, Sebastian, Tito, Raul Yhossef, Raes, Jeroen, Glorieux, Griet, Moosa, Mohammed Rafique, Blaauw, Renée
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880761/ https://www.ncbi.nlm.nih.gov/pubmed/35215453 http://dx.doi.org/10.3390/nu14040805

Ejemplares similares

Obesity and Other Nutrition Related Abnormalities in Pre-Dialysis Chronic Kidney Disease (CKD) Participants
por: Ebrahim, Zarina, et al.
Publicado: (2020)

Nutritional Status in Adults with Predialysis Chronic Kidney Disease: KNOW-CKD Study
por: Hyun, Young Youl, et al.
Publicado: (2017)

Chronic Kidney Disease and Fibrosis: The Role of Uremic Retention Solutes
por: Mutsaers, Henricus A. M., et al.
Publicado: (2015)

Deleting Death and Dialysis: Conservative Care of Cardio-Vascular Risk and Kidney Function Loss in Chronic Kidney Disease (CKD)
por: Vanholder, Raymond, et al.
Publicado: (2018)

Exploring Protein Binding of Uremic Toxins in Patients with Different Stages of Chronic Kidney Disease and during Hemodialysis
por: Deltombe, Olivier, et al.
Publicado: (2015)

Isolation and Quantification of Uremic Toxin Precursor-Generating Gut Bacteria in Chronic Kidney Disease Patients
por: Gryp, Tessa, et al.
Publicado: (2020)

Association between Protein-Bound Uremic Toxins and Asymptomatic Cardiac Dysfunction in Patients with Chronic Kidney Disease
por: Chinnappa, Shanmugakumar, et al.
Publicado: (2018)

What is new in uremic toxicity?
por: Vanholder, Raymond, et al.
Publicado: (2008)

Predialysis Potassium Variability and Postdialysis Mortality in Patients With Advanced CKD
por: Dashputre, Ankur A., et al.
Publicado: (2021)

Association between uremic toxin-anthranilic acid and fibrinolytic system activity in predialysis patients at different stages of chronic kidney disease
por: Kaminski, Tomasz W., et al.
Publicado: (2017)

Contribution of the uremic milieu to an increased pro-inflammatory monocytic phenotype in chronic kidney disease
por: Borges Bonan, Natalia, et al.
Publicado: (2019)

The intestine and the kidneys: a bad marriage can be hazardous
por: Vanholder, Raymond, et al.
Publicado: (2015)

Gut Microbiota and Their Derived Metabolites, a Search for Potential Targets to Limit Accumulation of Protein-Bound Uremic Toxins in Chronic Kidney Disease
por: Steenbeke, Mieke, et al.
Publicado: (2021)

Predialysis Care Experience Among Patients With CKD at a Teaching Hospital in Kenya
por: Kabinga, Samuel K., et al.
Publicado: (2019)

Uremic Toxin Concentrations are Related to Residual Kidney Function in the Pediatric Hemodialysis Population
por: Snauwaert, Evelien, et al.
Publicado: (2019)

Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update
por: Vanholder, Raymond, et al.
Publicado: (2018)

Selective Transport of Protein-Bound Uremic Toxins in Erythrocytes
por: Deltombe, Olivier, et al.
Publicado: (2019)

Estimated Glomerular Filtration Rate Is a Poor Predictor of the Concentration of Middle Molecular Weight Uremic Solutes in Chronic Kidney Disease
por: Neirynck, Nathalie, et al.
Publicado: (2012)

What If Not All Metabolites from the Uremic Toxin Generating Pathways Are Toxic? A Hypothesis
por: Vanholder, Raymond, et al.
Publicado: (2022)

The Association of Daily Activity Levels and Estimated Kidney Function in Men and Women With Predialysis Chronic Kidney Disease
por: West, Sarah L., et al.
Publicado: (2017)

Gut-Derived Metabolites and Their Role in Immune Dysfunction in Chronic Kidney Disease
por: Glorieux, Griet, et al.
Publicado: (2020)

The effect of ONCE Renal on minerals and electrolytes in predialysis patients with chronic kidney disease
por: Satirapoj, Bancha, et al.
Publicado: (2016)

Gallbladder Stone Prevalence and Related Factors in Predialysis Chronic Kidney Disease Patients
por: Yılmaz, Üstün, et al.
Publicado: (2022)

Effects of Fecal Microbiota Transplantation on Composition in Mice with CKD
por: Barba, Christophe, et al.
Publicado: (2020)

Management of Uremic Xerosis and Chronic Kidney Disease (CKD)-Associated Pruritus (CKD-ap) With Topical Preparations: A Systematic Review and Implications in the Indian Context
por: Verma, Veena, et al.
Publicado: (2023)

Effects of calcium-containing phosphate binders on cardiovascular events and mortality in predialysis CKD stage 5 patients
por: Tsai, Ping-Huang, et al.
Publicado: (2020)

Prevalence of anemia in predialysis chronic kidney disease: Is the study center a significant factor?
por: Alagoz, Selma, et al.
Publicado: (2020)

The Impact of Bone Mineral Biomarkers on Cardiac Dysfunction in Predialysis Chronic Kidney Disease Children
por: Ali, Safaa, et al.
Publicado: (2021)

Association between predialysis creatinine and mortality in acute kidney injury patients requiring dialysis
por: Chang, Hsin-Hsiung, et al.
Publicado: (2022)

Predialysis trajectories of estimated GFR and concurrent trends of Chronic Kidney Disease-relevant biomarkers
por: Tsao, Hsiao-Mei, et al.
Publicado: (2023)

The Impact of CKD on Uremic Toxins and Gut Microbiota
por: Rysz, Jacek, et al.
Publicado: (2021)

The AKI-to-CKD Transition: The Role of Uremic Toxins
por: André, Camille, et al.
Publicado: (2023)

Does the Adequacy Parameter Kt/V(urea) Reflect Uremic Toxin Concentrations in Hemodialysis Patients?
por: Eloot, Sunny, et al.
Publicado: (2013)

Feeding cats with chronic kidney disease food supplemented with betaine and prebiotics increases total body mass and reduces uremic toxins
por: Hall, Jean A., et al.
Publicado: (2022)

Assessment of some cardiovascular risk factors in predialysis chronic kidney disease patients in Southern Nigeria
por: Adejumo, Oluseyi A., et al.
Publicado: (2015)

Effect of Bicarbonate Supplementation on Renal Function and Nutritional Indices in Predialysis Advanced Chronic Kidney Disease
por: Jeong, Jiwon, et al.
Publicado: (2014)

Ezetimibe and simvastatin for the prevention of cardiovascular events in predialysis chronic kidney disease patients: a review
por: Naderi, Sahar, et al.
Publicado: (2012)

Association between E/e´ ratio and fluid overload in patients with predialysis chronic kidney disease
por: Kim, Jae-Seok, et al.
Publicado: (2017)

Determinants of quality of life as measured with variants of SF-36 in patients with predialysis chronic kidney disease
por: Alhaji, Mohammed M., et al.
Publicado: (2018)

Optimal predialysis care
por: Sijpkens, Yvo W. J., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_0o4gdlbdqo0ma8kg9hlnt9i5mp